May 14, 2020 / 7:29 PM / 16 days ago

IN BRIEF: Activist investor settles SEC case over Sinovac board replacement plan

An activist investor and his firm will pay $290,000 to resolve charges by U.S. securities regulators that they failed to disclose their increasing stake in Sinovac Biotech and their participation in a plan to replace the Chinese biopharmaceutical company’s board.

The U.S. Securities and Exchange Commission disclosed the settlement on Wednesday in an administrative order charging Jiaqiang “Chiang” Li and his Boston-based firm, 1Globe Capital LLC, with violating federal securities laws and SEC rules.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below